Inhibition of tumour necrosis factor-α in patients with chronic hepatitis C infection

被引：0
|
作者：
C. Zavos
J. Kountouras
N. Zavos
D. Chatzopoulos
机构：
[1] Aristotle University of Thessaloniki,Department of Gastroenterology, Second Medical Clinic
[2] Ippokration Hospital,undefined
来源：
Clinical Rheumatology | 2007年 / 26卷
关键词：
Chronic Hepatitis; Spondylitis; Psoriatic Arthritis; Alanine Transaminase; Viral Reactivation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：283 / 283
相关论文
共 50 条
  • [21] Plasma levels of tumour necrosis factor-α in patients with chronic periodontitis and type 2 diabetes
    Engebretson, S.
    Chertog, R.
    Nichols, A.
    Hey-Hadavi, J.
    Celenti, R.
    Grbic, J.
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2007, 34 (01) : 18 - 24
  • [22] Tumour necrosis factor alpha polymorphisms are not involved in the development of steatosis in chronic hepatitis C
    Sánchez-Muñoz, D
    Romero-Gómez, M
    González-Escribano, MF
    Torres, B
    Castellano-Megias, VM
    Gómez-Izquierdo, L
    Aguilar-Reina, J
    Nuñez-Roldan, A
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (08) : 761 - 765
  • [23] Tumor Necrosis Factor-α Promoter Gene Polymorphisms Are Not Associated with Hepatitis C Virus Infection in Chinese Hemodialysis Patients
    Zhang, Xiaoli
    Hu, Dalan
    Zhu, Bei
    Wang, Cuiyu
    He, Juan
    Wu, Jianqing
    Yu, Rong Bin
    Zhao, Wei Hong
    RENAL FAILURE, 2011, 33 (06) : 593 - 599
  • [24] Intrahepatic expression of interleukin-1β and tumor necrosis factor-α in chronic hepatitis C
    Dumoulin, FL
    Leifeld, L
    Honecker, U
    Sauerbruch, T
    Spengler, U
    JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (05): : 1704 - 1708
  • [25] Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients
    Radwan, Mohamed I.
    Pasha, Heba F.
    Mohamed, Rasha H.
    Hussien, Hala I. M.
    El-Khshab, Mohamed N.
    CYTOKINE, 2012, 60 (01) : 271 - 276
  • [26] Serum values of tumour necrosis factor-α and of soluble tumour necrosis factor-R55 in melanoma patients
    Ocvirk, J
    Stabuc, B
    Rudolf, Z
    Galvani, V
    Curin-Serbec, V
    MELANOMA RESEARCH, 2000, 10 (03) : 253 - 258
  • [27] Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo
    Webb, K. C.
    Tung, R.
    Winterfield, L. S.
    Gottlieb, A. B.
    Eby, J. M.
    Henning, S. W.
    Le Poole, I. C.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (03) : 641 - 650
  • [28] Association between tumour necrosis factor gene polymorphisms and the clinical types of patients with chronic hepatitis B virus infection
    Xu, XW
    Lu, MH
    Tan, DM
    CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (01) : 52 - 56
  • [29] Safety of antitumour necrosis factor-α therapy in psoriatic patients with hepatitis B virus infection
    Nosotti, L.
    Francesconi, F.
    Izzi, S.
    Berardesca, E.
    Morrone, A.
    Bonifati, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 162 (06) : 1408 - 1410
  • [30] Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection
    Yee, LJ
    Tang, J
    Herrera, J
    Kaslow, RA
    van Leeuwen, DJ
    GENES AND IMMUNITY, 2000, 1 (06) : 386 - 390
12345